PET/MRI Machine Learning Model Can Eliminate Sentinel Lymph Node Biopsy in Majority of Breast Cancer Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Simple MRI Measurement Could Avoid 30% of Breast Biopsies
Scientific findings are instantly applicable in clinical practice
March 9, 2021 Breast cancer is the most common fatal cancer in women. Early detection increases a woman s chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue. However, it sometimes causes false alarms , thus requiring further investigation (biopsy) and in some cases even resulting in so-called overtreatment, that is to say unnecessary surgery. For the first time, a research team from MedUni Vienna has now confirmed a threshold value for a non-invasive imaging biomarker. This can be incorporated into short standard MRI scans and could reduce the biopsy rate following MRI scans by 30%. Since the infrastructure for this measurement already exists in every radiological facility in Austria, the biomarker could be immediately deployed countrywide.
Researchers confirm a threshold value for non-invasive imaging biomarker
Breast cancer is the commonest fatal cancer in women. Early detection increases a woman s chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue.
However, it sometimes causes false alarms , thus requiring further investigation (biopsy) and in some cases even resulting in so-called overtreatment, that is to say, unnecessary surgery. For the first time, a research team from MedUni Vienna has now confirmed a threshold value for a non-invasive imaging biomarker.
This can be incorporated into short standard MRI scans and could reduce the biopsy rate following MRI scans by 30%. Since the infrastructure for this measurement already exists in every radiological facility in Austria, the biomarker could be immediately deployed countrywide.
Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumours in breast tissue. However, it sometimes causes false alarms , thus requiring further investigation (biopsy) and in some cases even resulting in so-called overtreatment, that is to say unnecessary surgery. For the first time, a research team from MedUni Vienna has now confirmed a threshold value for a non-invasive imaging biomarker. This can be incorporated into short standard MRI scans and could reduce the biopsy rate following MRI scans by 30%.